Companies across the country are trotting out all sorts of new incentives to entice workers to trade in their sweatpants and mid-day naps for office life, per The Globe and Mail.
When it comes to the weight loss drug race, Ely Lilly might have found the biggest loser.
Driving the news: The US pharma giant is looking to get its Type II diabetes drug Mounjaro approved for use in weight loss. And some people are already using it that way.
Apple’s first-ever retail store in India is set to open any day now, but that’s hardly the only move the giant-est tech giant is making into the world’s fastest-growing major economy.
Canadian clothier Aritzia has made bank as it expands in the US, but a copyright infringement suit against its viral storefront sculptures could make its pockets a little lighter.
Hot off of WrestleMania, the world’s largest pro wrestling company is linking up with the world’s biggest mixed martial arts brand to bodyslam their way to bigger broadcast deals.
Well, it took 746 days, a tribunal, four deadline extensions, and a whole whack of explainers, but the end is finally here for the telecoms saga you’ve kinda, sorta been paying attention to.